Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04243512 · ClinicalTrials.gov registry record · NA
Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT04243512: Completed NA study, sponsored by University of Rochester.
NCT04243512 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04243512, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The investigators will assess the feasibility of delivering a time-restricted eating (TRE) intervention among cancer survivors with fatigue.
Primary Outcome
Adherence will be assessed as the percent of days that each participant adheres to the 10-h TRE dietary pattern
Interventions
- BEHAVIORAL Time-restricted eating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2020-06-30 |
| Est. Completion | 2022-06-29 |
| Phase | NA |
What the finished NCT04243512 record still lists
NCT04243512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Time-restricted eating is the first listed.
NCT04243512 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04243512 about?
NCT04243512 is a clinical study titled "Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study". The investigators will assess the feasibility of delivering a time-restricted eating (TRE) intervention among cancer survivors with fatigue.
What is the current status of trial NCT04243512?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2020-06-30. Estimated completion is 2022-06-29.
What interventions are being tested in trial NCT04243512?
The interventions under investigation include: Time-restricted eating (BEHAVIORAL).
Who is sponsoring clinical trial NCT04243512?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04243512's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI